Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation
Sara Federici(Weizmann Institute of Science), Nitsan Maharshak(Yale University), Corinna Bang(Christian-Albrechts-Universität zu Kiel), Wolfgang Lieb(Christian-Albrechts-Universität zu Kiel), Edith Kario(3D Biomatrix (United States)), Hava Ben‐David(3D Biomatrix (United States)), Claudia Moresi(Weizmann Institute of Science), Yulia Matiuhin(Technion – Israel Institute of Technology), Dana Inbar(3D Biomatrix (United States)), Denise Kviatcovsky(Weizmann Institute of Science), Inbar Gahali-Sass(3D Biomatrix (United States)), Sharon Kredo‐Russo(3D Biomatrix (United States)), Christoph Schramm(European Association for the Study of Diabetes), Vered Lev(3D Biomatrix (United States)), Munehiro Furuichi(Keio University), Noa Stettner(Weizmann Institute of Science), Yael Friedman Geffen(3D Biomatrix (United States)), Noa Ben-Yishai(3D Biomatrix (United States)), Urania Rappo(3D Biomatrix (United States)), Koji Atarashi(RIKEN Center for Integrative Medical Sciences), Gayatree Mohapatra(Weizmann Institute of Science), Hagit Shapiro(Weizmann Institute of Science), Akihiko Oka(Shimane University), Lara Kern(Max Planck Institute for Metabolism Research), Samuel Philip Nobs(Weizmann Institute of Science), Julian Nicenboim(3D Biomatrix (United States)), Efrat Khabra(3D Biomatrix (United States)), Eyal Weinstock(Weizmann Institute of Science), Iddo Weiner(3D Biomatrix (United States)), Danping Zheng(Sun Yat-sen University), Morine Fibelman(Tel Aviv Sourasky Medical Center), Yael Silberberg(Tel Aviv University), André Franke(Christian-Albrechts-Universität zu Kiel), Myriam Golembo(3D Biomatrix (United States)), Rafael Valdés‐Mas(Weizmann Institute of Science), Lior Zelcbuch(3D Biomatrix (United States)), Harry Sokol(AgroParisTech), Kenya Honda(Keio University), Mally Dori-Bachash(Weizmann Institute of Science), Jotham Suez(Weizmann Institute of Science), Noga Kowalsman(3D Biomatrix (United States)), Alon Harmelin(Weizmann Institute of Science), Nyssa Cullin(Heidelberg University), Bo Liu(Capital Medical University), Amanda Cuevas‐Sierra(Madrid Institute for Advanced Studies), Tal Cohen(3D Biomatrix (United States)), Ariel Cohen(3D Biomatrix (United States)), Naomi B. Zak(Mapi Pharma (Israel)), Merav Bassan(Mapi Pharma (Israel)), Sailaja Puttagunta(3D Biomatrix (United States))
Cited by 504
Related Papers
Interaction between microbiota and immunity in health and disease
|Cell Research|2020|3.8k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Large-scale association analyses identify host factors influencing human gut microbiome composition
|Nature Genetics|2021|1.9k